Analysis of the binding of gluten T-cell epitopes to various human leukocyte antigen class II molecules

Human Immunology

Volumn 69, Issue 2, 2008, Pages 94-100

  Bergseng, Elin ^b   Sidney, John ^c   Sette, Alessandro ^c   Sollid, Ludvig M ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Celiac disease; DQ2; Gluten T cell epitopes; HLA class II molecules; Peptide binding

Indexed keywords

GLUTEN; HLA A2 ANTIGEN;

ARTICLE; CELIAC DISEASE; CELL LYSATE; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; T LYMPHOCYTE;

ANTIGEN PRESENTATION; BINDING SITES; BINDING, COMPETITIVE; CD4-POSITIVE T-LYMPHOCYTES; CELIAC DISEASE; EPITOPES, T-LYMPHOCYTE; GENETIC PREDISPOSITION TO DISEASE; GLUTEN; HLA-D ANTIGENS; HLA-DQ ANTIGENS; HUMANS; HYDROGEN BONDING; PEPTIDE FRAGMENTS; RADIOLIGAND ASSAY;

EID: 40949132466     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.01.002     Document Type: Article

References (49)

1. Maki M., Mustalahti K., Kokkonen J., Kulmala P., Haapalahti M., Karttunen T., et al. Prevalence of celiac disease among children in Finland. N Engl J Med 348 (2003) 2517
2. Sollid L.M. Coeliac disease: Dissecting a complex inflammatory disorder. Nat Rev Immunol 2 (2002) 647
3. Stern L.J., Brown J.H., Jardetzky T.S., Gorga J.C., Urban R.G., Strominger J.L., et al. Crystal-structure of the human class-II MHC protein HLA-DR1 complexed with an influenza-virus peptide. Nature 368 (1994) 215
4. Lundin K.E., Scott H., Hansen T., Paulsen G., Halstensen T.S., Fausa O., et al. Gliadin-specific, HLA-DQ(α1*0501,β1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 178 (1993) 187
5. Lundin K.E., Scott H., Fausa O., Thorsby E., and Sollid L.M. T cells from the small intestinal mucosa of a DR4, DQ7/DR4, DQ8 celiac disease patient preferentially recognize gliadin when presented by DQ8. Hum Immunol 41 (1994) 285
6. Molberg Ø., Kett K., Scott H., Thorsby E., Sollid L.M., and Lundin K.E. Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand J Immunol 46 (1997) 103
7. Qiao S.W., Bergseng E., Molberg Ø., Jung G., Fleckenstein B., and Sollid L.M. Refining the rules of gliadin T cell epitope binding to the disease associated DQ2 molecule in celiac disease; importance of proline spacing and glutamine deamidation. J Immunol 175 (2005) 254
8. Kim C.Y., Quarsten H., Bergseng E., Khosla C., and Sollid L.M. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci USA 101 (2004) 4175
9. Nelson C.A., and Fremont D.H. Structural principles of MHC class II antigen presentation. Rev Immunogenet 1 (1999) 47
10. Bergseng E., Xia J., Kim C.Y., Khosla C., and Sollid L.M. Main chain hydrogen bond interactions in the binding of proline-rich gluten peptides to the celiac disease associated HLA-DQ2 molecule. J Biol Chem 280 (2005) 21791
11. Clot F., Gianfrani C., Babron M.C., Bouguerra F., Southwood S., Kagnoff M.F., et al. HLA-DR53 molecules are associated with susceptibility to celiac disease and selectively bind gliadin-derived peptides. Immunogenetics 49 (1999) 800
12. Hume C.R., Shookster L.A., Collins N., O'Reilly R., and Lee J.S. Bare lymphocyte syndrome: Altered HLA class II expression in B cell lines derived from two patients. Hum Immunol 25 (1989) 1
13. Lampson L.A., and Levy R. Two populations of Ia-like molecules on a human B cell line. J Immunol 125 (1980) 293
14. Rebai N., Malissen B., Pierres M., Accolla R.S., Corte G., and Mawas C. Distinct HLA-DR epitopes and distinct families of HLA-DR molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb. Eur J Immunol 13 (1983) 106
15. Knudsen P.J., and Strominger J.L. A monoclonal antibody that recognizes the α chain of HLA-DR antigens. Hum Immunol 15 (1986) 150
16. Spits H., Borst J., Giphart M., Coligan J., Terhorst C., and De Vries J.E. HLA-DC antigens can serve as recognition elements for human cytotoxic T lymphocytes. Eur J Immunol 14 (1984) 299
17. Viken H.D., Paulsen G., Sollid L.M., Lundin K.E.A., Tjonnfjord G.E., Thorsby E., et al. Characterization of an HLA-DQ2-specific monoclonal antibody-influence of amino acid substitutions in DQβ1*0202. Hum Immunol 42 (1995) 319
18. Robbins P.A., Evans E.L., Ding A.H., Warner N.L., and Brodsky F.M. Monoclonal antibodies that distinguish between class II antigens (HLA-DP, DQ, and DR) in 14 haplotypes. Hum Immunol 18 (1987) 301
19. Johansen B.H., Buus S., Vartdal F., Viken H., Eriksen J.A., Thorsby E., et al. Binding of peptides to HLA-DQ molecules: peptide binding properties of the disease-associated HLA-DQ(α1*0501, β1*0201) molecule. Int Immunol 6 (1994) 453
20. 131I-labelled human growth hormone of high specific radioactivity. Biochem J 89 (1963) 114
21. Buus S., Stryhn A., Winther K., Kirkby N., and Pedersen L.O. Receptor-ligand interactions measured by an improved spun column chromatography technique. A high efficiency and high throughput size separation method. Biochim Biophys Acta 1243 (1995) 453
22. Quarsten H., McAdam S.N., Jensen T., Arentz-Hansen H., Molberg Ø., Lundin K.E., et al. Staining of celiac disease-relevant T cells by peptide-DQ2 multimers. J Immunol 167 (2001) 4861
23. Sloan V.S., Cameron P., Porter G., Gammon M., Amaya M., Mellins E., et al. Mediation by HLA-DM of dissociation of peptides from HLA-DR. Nature 375 (1995) 802
24. Sidney J., Southwood S., Oseroff C., del Guercio M.F., and Sette A. Measurement of MHC/peptide interactions by gel filtration. In: Coico R. (Ed). Current protocols in immunology (1998) Hoboken, Wiley.
25. Southwood S., Sidney J., Kondo A., del Guercio M.F., Appella E., Hoffman S., et al. Several common HLA-DR types share largely overlapping peptide binding repertoires. J Immunol 160 (1998) 3363
26. Stepniak D., Vader L.W., Kooy Y., Van Veelen P.A., Moustakas A., Papandreou N.A., et al. T-cell recognition of HLA-DQ2-bound gluten peptides can be influenced by an N-terminal proline at p-1. Immunogenetics 57 (2005) 8
27. Straumfors A., Johansen B.H., Vartdal F., Sollid L.M., Thorsby E., and Buus S. A peptide-binding assay for the disease-associated HLA-DQ8 molecule. Scand J Immunol 47 (1998) 561
28. Geluk A., Bloemhoff W., de Vries R.R., and Ottenhoff T.H. Binding of a major T cell epitope of mycobacteria to a specific pocket within HLA-DRw17(DR3) molecules. Eur J Immunol 22 (1992) 107
29. Chicz R.M., Graziano D.F., Trucco M., Strominger J.L., and Gorga J.C. HLA-DP2: self peptide sequences and binding properties. J Immunol 159 (1997) 4935
30. Shan L., Molberg Ø., Parrot I., Hausch F., Filiz F., Gray G.M., et al. Structural basis for gluten intolerance in celiac sprue. Science 297 (2002) 2275
31. Shan L., Qiao S.W., Arentz-Hansen H., Molberg Ø., Gray G.M., Sollid L.M., et al. Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue. J Proteome Res 4 (2005) 1732
32. Molberg Ø., McAdam S.N., Körner R., Quarsten H., Kristiansen C., Madsen L., et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 4 (1998) 713
33. van de Wal Y., Kooy Y., van Veelen P., Pena S., Mearin L., Papadopoulos G., et al. Cutting edge: selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J Immunol 161 (1998) 1585
34. Sjöström H., Lundin K.E., Molberg Ø., Körner R., McAdam S.N., Anthonsen D., et al. Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand J Immunol 48 (1998) 111
35. Arentz-Hansen H., Körner R., Molberg Ø., Quarsten H., Vader W., Kooy Y.M., et al. The intestinal T cell response to α-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 191 (2000) 603
36. Vader W., Kooy Y., van Veelen P., de Ru A., Harris D., Benckhuijsen W., et al. The gluten response in children with celiac disease is directed toward multiple gliadin and glutenin peptides. Gastroenterology 122 (2002) 1729
37. Arentz-Hansen H., McAdam S.N., Molberg Ø., Fleckenstein B., Lundin K.E., Jørgensen T.J., et al. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology 123 (2002) 803
38. van de Wal Y., Kooy Y.M., Van Veelen P.A., Pena S.A., Mearin L.M., Molberg O., et al. Small intestinal T cells of celiac disease patients recognize a natural pepsin fragment of gliadin. Proc Natl Acad Sci USA 95 (1998) 10050
39. van de Wal Y., Kooy Y.M., van Veelen P., Vader W., August S.A., Drijfhout J.W., et al. Glutenin is involved in the gluten-driven mucosal T cell response. Eur J Immunol 29 (1999) 3133
40. Tollefsen S., Arentz-Hansen H., Fleckenstein B., Molberg Ø., Raki M., Kwok W.W., et al. HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease. J Clin Invest 116 (2006) 2226
41. Sollid L.M., and Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterology 105 (1993) 910
42. Karell K., Louka A.S., Moodie S.J., Ascher H., Clot F., Greco L., et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the european genetics cluster on celiac disease. Hum Immunol 64 (2003) 469
43. Quarsten H., Molberg Ø., Fugger L., McAdam S.N., and Sollid L.M. HLA binding and T cell recognition of a tissue transglutaminase-modified gliadin epitope. Eur J Immunol 29 (1999) 2506
44. Vader W., Stepniak D., Kooy Y., Mearin L., Thompson A., van Rood J.J., et al. The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses. Proc Natl Acad Sci USA 100 (2003) 12390
45. Johansen B.H., Jensen T., Thorpe C.J., Vartdal F., Thorsby E., and Sollid L.M. Both α and β chain polymorphisms determine the specificity of the disease-associated HLA-DQ2 molecules, with beta chain residues being most influential. Immunogenetics 45 (1996) 142
46. van de Wal Y., Kooy Y.M., Drijfhout J.W., Amons R., Papadopoulos G.K., and Koning F. Unique peptide binding characteristics of the disease-associated DQ(α1*0501, β1*0201) vs the non-disease-associated DQ(α1*0201, β1*0202) molecule. Immunogenetics 46 (1997) 484
47. van Schooten W.C., Elferink D.G., van Embden J., Anderson D.C., and de Vries R.R. DR3-restricted T cells from different HLA-DR3-positive individuals recognize the same peptide (amino acids 2-12) of the mycobacterial 65-kDa heat-shock protein. Eur J Immunol 19 (1989) 2075
48. Gorga J.C., Horejsi V., Johnson D.R., Raghupathy R., and Strominger J.L. Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line. J Biol Chem 262 (1987) 16087
49. Castelli F.A., Buhot C., Sanson A., Zarour H., Pouvelle-Moratille S., Nonn C., et al. HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity. J Immunol 169 (2002) 6928